The Epredia mission is in action. And we’re just getting started.

Epredia was founded in July 2019 with the acquisition of PHC Group from Thermo Fisher Scientific. Backed by trusted brands such as Shandon, Microm, Menzel Gläser and Richard-Allan Scientific, Epredia has a broad range of solutions that have transformed and will continue to transform the anatomic pathology market.

Today, we are a global precision cancer diagnostics company committed to improving patient outcomes by providing groundbreaking technologies. Since our humble beginnings in 1937, every product developed has been influenced by generations of employees dedicated to improving lives by enabling pathologists to advance precision cancer diagnostics.